<DOC>
	<DOCNO>NCT00783354</DOCNO>
	<brief_summary>This double-blind pilot study conduct establish best way use desloratadine treatment protect quality life chronic idiopathic urticaria ( CIU ) patient , initial 4-weeks daily treatment : prolonging systematic daily treatment need ( PRN ; case symptom ) .</brief_summary>
	<brief_title>A Comparison Aerius Continuous Treatment Versus Aerius PRN Chronic Idiopathic Urticaria ( Study P03147 )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Subjects must demonstrate willingness participate study comply procedure sign write informed consent . Subjects must &gt; = 18 year age Women childbearing potential must negative urine pregnancy test Visit 1 ( Day 1 ) must use acceptable method birth control study . Subjects must general good health ; ie , must free clinically significant disease ( CIU ) would interfere study evaluation . Subjects must understand able adhere visit schedule , agree complete questionnaire diary . Subjects must least 6week history CIU ( pruritus hive ) prior Visit 1 . Women pregnant nursing . Subjects use investigational drug last 30 day prior Visit 1 Subjects asthma require chronic use inhale systemic corticosteroid . Subjects treat investigational antibody asthma allergic rhinitis 90 day prior Baseline . Subjects treat intramuscular intraarticular corticosteroid 90 day prior Baseline . Subjects urticaria primarily due physical urticaria know etiology , except dermographism . Subjects treat immunosuppressive drug . Subjects hospitalize ( include emergency department visit ) deterioration CIU within 3 month prior Visit 1 . Subjects history hypersensitivity desloratadine excipients . Subjects previously randomize study . Subjects clinically significant metabolic , cardiovascular , immunological , neurological , hematological , gastrointestinal , cerebrovascular , respiratory disease , disorder , judgment investigator , may interfere study evaluation affect subject safety . Subjects history psychosis , antagonistic personality , poor motivation , hypochondriasis , emotional intellectual problem likely limit validity consent participate study . Subjects history noncompliance medication treatment protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>